FERROUS ANHYDROUS: 494 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
494
Total FAERS Reports
47 (9.5%)
Deaths Reported
268
Hospitalizations
494
As Primary/Secondary Suspect
37
Life-Threatening
2
Disabilities
Active Ingredient: FERROUS SULFATE ANHYDROUS ·
First Report: 20010111 · Latest Report: 20220409
What Are the Most Common FERROUS ANHYDROUS Side Effects?
#1 Most Reported
Asthma
190 reports (38.5%)
#2 Most Reported
Full blood count abnormal
160 reports (32.4%)
#3 Most Reported
Gastrooesophageal reflux disease
151 reports (30.6%)
All FERROUS ANHYDROUS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 190 | 38.5% | 13 | 95 |
| Full blood count abnormal | 160 | 32.4% | 13 | 79 |
| Gastrooesophageal reflux disease | 151 | 30.6% | 0 | 56 |
| Dyspnoea | 106 | 21.5% | 13 | 105 |
| Wheezing | 103 | 20.9% | 11 | 102 |
| Hyperglycaemia | 95 | 19.2% | 0 | 0 |
| Type 2 diabetes mellitus | 95 | 19.2% | 0 | 0 |
| Obstructive airways disorder | 83 | 16.8% | 13 | 83 |
| Sleep disorder due to a general medical condition | 81 | 16.4% | 12 | 81 |
| Therapeutic product effect incomplete | 75 | 15.2% | 11 | 75 |
| Foetal exposure during pregnancy | 74 | 15.0% | 6 | 19 |
| Condition aggravated | 70 | 14.2% | 13 | 70 |
| Rhinorrhoea | 69 | 14.0% | 0 | 69 |
| Chronic obstructive pulmonary disease | 66 | 13.4% | 0 | 66 |
| Secretion discharge | 65 | 13.2% | 0 | 65 |
| Loss of personal independence in daily activities | 63 | 12.8% | 11 | 63 |
| Respiratory tract infection | 59 | 11.9% | 3 | 59 |
| Dyspnoea exertional | 57 | 11.5% | 0 | 57 |
| Eczema | 57 | 11.5% | 0 | 57 |
| Nasal congestion | 57 | 11.5% | 0 | 56 |
Who Reports FERROUS ANHYDROUS Side Effects? Age & Gender Data
Gender: 80.1% female, 19.9% male. Average age: 54.7 years. Most reports from: CA. View detailed demographics →
Is FERROUS ANHYDROUS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 2 | 0 | 2 |
| 2015 | 6 | 3 | 5 |
| 2016 | 4 | 1 | 2 |
| 2017 | 1 | 0 | 0 |
| 2018 | 11 | 0 | 0 |
| 2019 | 5 | 0 | 5 |
| 2020 | 3 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
What Is FERROUS ANHYDROUS Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 377 |
| Supplementation therapy | 30 |
| Anaemia | 28 |
| Hiv infection | 17 |
| Foetal exposure during pregnancy | 16 |
| Maternal exposure timing unspecified | 10 |
FERROUS ANHYDROUS vs Alternatives: Which Is Safer?
FERROUS ANHYDROUS vs FERROUS GLYCINE
FERROUS ANHYDROUS vs FERROUS\FERROUS, DRIED
FERROUS ANHYDROUS vs FERROUS\FOLIC ACID
FERROUS ANHYDROUS vs FERUMOXYTOL
FERROUS ANHYDROUS vs FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE
FERROUS ANHYDROUS vs FESOTERODINE
FERROUS ANHYDROUS vs FEXOFENADINE
FERROUS ANHYDROUS vs FEXOFENADINE OTC
FERROUS ANHYDROUS vs FEXOFENADINE\FEXOFENADINE
FERROUS ANHYDROUS vs FEXOFENADINE\PSEUDOEPHEDRINE
Official FDA Label for FERROUS ANHYDROUS
Official prescribing information from the FDA-approved drug label.